Dalloz F - Search Results

1

Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography.

Cottin Y, Touzery C, Dalloz F, Coudert B, Toubeau M, Riedinger A, Louis P, Wolf JE, Brunotte F. Cottin Y, et al. Among authors: dalloz f. Clin Cardiol. 1998 Sep;21(9):665-70. doi: 10.1002/clc.4960210911. Clin Cardiol. 1998. PMID: 9755384 Free PMC article. Clinical Trial.

2

Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarction.

Cottin Y, Doise JM, Maupoil V, Tannière-Zeller M, Dalloz F, Maynadié M, Walker MK, Louis P, Carli PM, Wolf JE, Rochette L. Cottin Y, et al. Among authors: dalloz f. Fundam Clin Pharmacol. 1998;12(2):236-41. doi: 10.1111/j.1472-8206.1998.tb00947.x. Fundam Clin Pharmacol. 1998. PMID: 9565780 Clinical Trial.

3

Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat.

Dalloz F, Maingon P, Cottin Y, Briot F, Horiot JC, Rochette L. Dalloz F, et al. Free Radic Biol Med. 1999 Apr;26(7-8):785-800. doi: 10.1016/s0891-5849(98)00259-7. Free Radic Biol Med. 1999. PMID: 10232821

4

Antioxidant properties of aminoguanidine.

Courderot-Masuyer C, Dalloz F, Maupoil V, Rochette L. Courderot-Masuyer C, et al. Among authors: dalloz f. Fundam Clin Pharmacol. 1999;13(5):535-40. doi: 10.1111/j.1472-8206.1999.tb00358.x. Fundam Clin Pharmacol. 1999. PMID: 10520725

5

Studies by electron paramagnetic resonance of the importance of iron in the hydroxyl scavenging properties of ascorbic acid in plasma: effects of iron chelators.

Benderitter M, Maupoil V, Vergely C, Dalloz F, Briot F, Rochette L. Benderitter M, et al. Among authors: dalloz f. Fundam Clin Pharmacol. 1998;12(5):510-6. doi: 10.1111/j.1472-8206.1998.tb00979.x. Fundam Clin Pharmacol. 1998. PMID: 9794148

6

In vitro studies of interactions of NO. donor drugs with superoxide and hydroxyl radicals.

Dalloz F, Maupoil V, Lecour S, Briot F, Rochette L. Dalloz F, et al. Mol Cell Biochem. 1997 Dec;177(1-2):193-200. doi: 10.1023/a:1006821724773. Mol Cell Biochem. 1997. PMID: 9450662

7

Direct evidence of caeruloplasmin antioxidant properties.

Atanasiu RL, Stea D, Mateescu MA, Vergely C, Dalloz F, Briot F, Maupoil V, Nadeau R, Rochette L. Atanasiu RL, et al. Among authors: dalloz f. Mol Cell Biochem. 1998 Dec;189(1-2):127-35. doi: 10.1023/a:1006945713860. Mol Cell Biochem. 1998. PMID: 9879663

8

Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease.

Dalloz F, Osinska H, Robbins J. Dalloz F, et al. J Mol Cell Cardiol. 2001 Jan;33(1):9-25. doi: 10.1006/jmcc.2000.1289. J Mol Cell Cardiol. 2001. PMID: 11133219 Review.

9

[Genetically modified animal models in cardiovascular research].

Dalloz F, Osinska H, Robbins J. Dalloz F, et al. Rev Esp Cardiol. 2001 Jun;54(6):764-89. doi: 10.1016/s0300-8932(01)76391-9. Rev Esp Cardiol. 2001. PMID: 11412782 Free article. Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters